Department of Laboratory Medicine, Liuzhou People's Hospital, Liu Zhou 545006, China.
Liuzhou Key Laboratory of Precision Medicine for Viral Diseases, Liu Zhou 545006, China.
Comput Intell Neurosci. 2022 Sep 30;2022:5932512. doi: 10.1155/2022/5932512. eCollection 2022.
Gastric cancer (GC) is a primary cause of cancer death around the world. Previous studies have found that Drosha plays a significant role in the development of tumor cells. Soon after, we unexpectedly found that the expression of microRNA6778-5p (miR6778-5p) is unconventionally high in the gastric cancer cells low-expressing Drosha. So, we designed the Drosha interference sequence and recombined it into a lentiviral vector to construct Drosha knockdown lentivirus and transfected the Drosha knockdown lentivirus into gastric cancer cells to establish Drosha knockdown gastric cancer cell lines. We aimed to explore the effect of microRNA6778-5p on the proliferation of gastric cancer cells with Drosha knockdown and its intrinsic mechanism.
We designed the Drosha interference sequence and recombined it into a lentiviral vector to construct Drosha knockdown lentivirus and transfected the Drosha knockdown lentivirus into gastric cancer cells to establish Drosha knockdown gastric cancer cell lines. After transfecting miR6778-5p mimics and inhibitor into gastric cancer cell lines with Drosha knockdown, the expression levels of miR6778-5p mimics in Drosha low-expressing gastric cancer cells increased, while miR6778-5p inhibitor decreased the expression levels of miR6778-5p. The Cell Counting Kit-8 (CCK-8) experiment was used to detect the proliferation ability of gastric cancer cells after overexpression or knockdown of miR6778-5p and bioinformatics predicted the relationship between miR6778-5p and glycogen synthase kinase-3 (GSK3).
After infection with the Drosha knockdown lentivirus, Drosha's mRNA and protein levels were significantly downregulated in gastric cancer cells. The expression levels of miR6778-5p mimics in Drosha low-expressing gastric cancer cells increased, while miR6778-5p inhibitor decreased the expression levels of miR6778-5p. Overexpression of miR6778-5p significantly enhanced the proliferation ability of Drosha low-expression gastric cancer cells; on the contrary, knocking down miR6778-5p weakened the proliferation ability of Drosha low-expression gastric cancer cells. Bioinformatics predicted that miR6778-5p targeted glycogen synthase kinase-3 (GSK3) and the mRNA and protein levels of GSK3 decreased significantly after overexpression of miR6778-5p.
miR6778-5p promotes the proliferation of Drosha low-expressing gastric cancer cells by targeting GSK3.
胃癌(GC)是全球癌症死亡的主要原因。先前的研究发现 Drosha 在肿瘤细胞的发展中起着重要作用。不久之后,我们意外地发现低表达 Drosha 的胃癌细胞中 microRNA6778-5p(miR6778-5p)的表达水平异常升高。因此,我们设计了 Drosha 干扰序列,并将其重组到慢病毒载体中,构建 Drosha 敲低慢病毒,并将 Drosha 敲低慢病毒转染到胃癌细胞中,建立 Drosha 敲低胃癌细胞系。我们旨在探讨 microRNA6778-5p 对 Drosha 敲低的胃癌细胞增殖的影响及其内在机制。
我们设计了 Drosha 干扰序列,并将其重组到慢病毒载体中,构建 Drosha 敲低慢病毒,并将 Drosha 敲低慢病毒转染到胃癌细胞中,建立 Drosha 敲低胃癌细胞系。将 miR6778-5p 模拟物和抑制剂转染到 Drosha 敲低的胃癌细胞系中后,Drosha 低表达胃癌细胞中 miR6778-5p 模拟物的表达水平增加,而 miR6778-5p 抑制剂降低了 miR6778-5p 的表达水平。使用细胞计数试剂盒-8(CCK-8)实验检测 miR6778-5p 过表达或敲低后胃癌细胞的增殖能力,并通过生物信息学预测 miR6778-5p 与糖原合成酶激酶-3(GSK3)的关系。
感染 Drosha 敲低慢病毒后,胃癌细胞中 Drosha 的 mRNA 和蛋白水平显著下调。Drosha 低表达胃癌细胞中 miR6778-5p 模拟物的表达水平增加,而 miR6778-5p 抑制剂降低了 miR6778-5p 的表达水平。过表达 miR6778-5p 显著增强 Drosha 低表达胃癌细胞的增殖能力;相反,敲低 miR6778-5p 则削弱了 Drosha 低表达胃癌细胞的增殖能力。生物信息学预测 miR6778-5p 靶向糖原合成酶激酶-3(GSK3),过表达 miR6778-5p 后 GSK3 的 mRNA 和蛋白水平显著降低。
miR6778-5p 通过靶向 GSK3 促进 Drosha 低表达胃癌细胞的增殖。